Evidence map›Paper›PMID 25043739›Full record

ArticleHepatology (Baltimore, Md.)2015

Cooperation of C/EBP family proteins and chromatin remodeling proteins is essential for termination of liver regeneration.

Jingling Jin, Il-Hwa Hong, Kyle Lewis, Polina Iakova, Meghan Breaux, Yanjun Jiang, Emily Sullivan, Nicole Jawanmardi, Lubov Timchenko, Nikolai A Timchenko

Open access · greenAbstract read
In one paragraph

Article in Hepatology (Baltimore, Md.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Neuronal C/EBPβ Shortens the Lifespan via Inactivating NAMPT.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Genetic and Cellular Contributions to Liver Regeneration.Cold Spring Harbor perspectives in biology · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Liver regeneration: biological and pathological mechanisms and implications.Nature reviews. Gastroenterology & hepatology · 2021
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Jingling JinHuffington Center on Aging and Departments of Pathology and Immunology and Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX.
Il-Hwa Hong
Kyle Lewis
Polina Iakova
Meghan Breaux
Yanjun Jiang
Emily Sullivan
Nicole Jawanmardi
Lubov Timchenko
Nikolai A Timchenko
Baylor College of Medicine · USGyeongsang National University · KR

Funding

Molecular Mechanisms of C/EBP Alpha Mediated Growth ArrestR01GM055188 · NIGMS · CINCINNATI CHILDRENS HOSP MED CTR · PI TIMCHENKO, NIKOLAI A. · 1997 to 2013
$3.3M
Role of Age in Liver CancerR01CA159942 · NCI · CINCINNATI CHILDRENS HOSP MED CTR · PI TIMCHENKO, NIKOLAI A. · 2011 to 2015
$1.6M
NAFLD: Mechanisms and TreatmentsR01DK102597 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI TIMCHENKO, NIKOLAI A. · 2015 to 2018
$1.4M
NCI NIH HHS CA159942NCI NIH HHS R01 CA159942NIDDK NIH HHS R01 DK102597NIGMS NIH HHS GM551888NIGMS NIH HHS R01 GM055188
6 · The paper itself

Abstract

unlabelledLiver cancer is the fifth most common cancer. A highly invasive surgical resection of the liver tumor is the main approach used to eliminate the tumor. Mechanisms that terminate liver regeneration when the liver reaches the original size are not known. The aims of this work were to generate an animal model that fails to stop liver regeneration after surgical resections and elucidate mechanisms that are involved in termination of liver regeneration. Because epigenetic control of liver function has been previously implicated in the regulation of liver proliferation, we generated C/EBPα-S193A knockin mice, which have alterations in formation of complexes of C/EBP family proteins with chromatin remodeling proteins. The C/EBPα-S193A mice have altered liver morphology and altered liver function leading to changes of glucose metabolism and blood parameters. Examination of the proliferative capacity of C/EBPα-S193A livers showed that livers of S193A mice have a higher rate of proliferation after birth, but stop proliferation at the age of 2 months. These animals have increased liver proliferation in response to liver surgery as well as carbon tetrachloride (CCl4 )-mediated injury. Importantly, livers of C/EBPα-S193A mice fail to stop liver regeneration after surgery when livers reach the original, preresection, size. The failure of S193A livers to stop regeneration correlates with the epigenetic repression of key regulators of liver proliferation C/EBPα, p53, FXR, SIRT1, PGC1α, and TERT by C/EBPβ-HDAC1 complexes. The C/EBPβ-HDAC1 complexes also repress promoters of enzymes of glucose synthesis PEPCK and G6Pase.

conclusionProper cooperation of C/EBP and chromatin remodeling proteins is essential for the termination of liver regeneration after surgery and for maintenance of liver functions.

Indexed as

Liver RegenerationAnimalsCCAAT-Enhancer-Binding ProteinsCell CycleChemical and Drug Induced Liver InjuryGlucose-6-PhosphataseHepatectomyHepatocytesHistone Deacetylase 1LiverMaleMicePeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPhosphoenolpyruvate Carboxykinase (GTP)Sirtuin 1TelomeraseCCAAT-Enhancer-Binding ProteinsGlucose-6-PhosphataseHdac1 protein, mouseHistone Deacetylase 1Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPhosphoenolpyruvate Carboxykinase (GTP)Ppargc1a protein, mouseSirt1 protein, mouseSirtuin 1TelomeraseTert protein, mouseTranscription FactorsTumor Suppressor Protein p53

Identifiers

PMID25043739
PMCPMC4280321
OpenAlexW2164647158

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.